(Q37187366)

18 August 2017

1 reference

title

Diastolic heart failure: mechanisms and controversies (English)

1 reference

Heart failure with preserved ejection fraction

18 August 2017

0 references

1 reference

1 reference

Maral Ouzounian

1

1 reference

PubMed ID

18542106

18 August 2017

Douglas S Lee

series ordinal

2

1 reference

PubMed ID

18542106

18 August 2017

Peter P Liu

series ordinal

3

1 reference

18 August 2017

10 June 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

7

1 reference

18 August 2017

375-386

1 reference

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

Monomeric phospholamban overexpression in transgenic mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Cardiomyocyte Stiffness in Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Titin isoform switch in ischemic human heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Mechanisms of exercise intolerance: insights from tissue Doppler imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Epidemiology and etiology of cardiomyopathy in Africa

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Epidemiology of diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Novel markers for heart failure diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Defining diastolic heart failure: a call for standardized diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The pathogenesis of acute pulmonary edema associated with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Prognosis in Heart Failure with a Normal Ejection Fraction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic function: a sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic dysfunction and left atrial volume: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Phospholamban: a crucial regulator of cardiac contractility

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

SERCA pump level is a critical determinant of Ca(2+)homeostasis and cardiac contractility

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Human SERCA2a levels correlate inversely with age in senescent human myocardium.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

New insights into diastolic heart failure: role of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic dysfunction in human cardiac allografts is related with reduced SERCA2a gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Titin: physiological function and role in cardiomyopathy and failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Afterload induced changes in myocardial relaxation A mechanism for diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1245

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1245

1 reference

18 August 2017

1 reference

PubMed ID

18542106